Private Equity
The most sought-after targets are small- to mid-sized companies focused on high-growth therapeutic areas, such as oncology, cardiometabolic, immunology, central nervous system and rare diseases.
5 min read · 08 January 2024
ARC Health is a group of mental healthcare practices.
1 min read · 05 January 2024
Gabriel Gomez, Adam La Reau, and Paul McCullough will continue to lead O2X, along with the entirety of the existing management team.
1 min read · 05 January 2024
Harris Williams LLC acted as financial advisor to EHOB on the deal.
1 min read · 05 January 2024
The buyer is Elevance Health.
1 min read · 04 January 2024
RhythMedix’s existing management team is reinvesting alongside Pharos and will remain with the company in their current roles.
1 min read · 04 January 2024
GP stakes, healthcare and Middle Eastern investors will be front of mind for Asia-Pacific markets in 2024.
5 min read · 04 January 2024
For Rite Aid’s 1,900 remaining retail stores, the company will receive bids for the physical store assets through January 19.
2 min read · 03 January 2024
Heart + Paw will continue to be led by its existing management team, including founder and Chief Veterinary Officer Dr. George Melillo, and CEO Dave Lasus.
1 min read · 03 January 2024
APC founder and CEO Dr. Edward Kowlowitz will remain a significant equity holder.
1 min read · 03 January 2024
